Epigenetically silenced long noncoding-SRHC promotes proliferation of hepatocellular carcinoma

Journal of Cancer Research and Clinical Oncology

Volumn 141, Issue 7, 2015, Pages 1195-1203

  Zheng, Hao ^a   Yang, Sen ^a   Yang, Yuan ^a   Yuan, Sheng Xian ^a   Wu, Fu Quan ^a   Wang, Li Li ^a   Yan, Hong Li ^a,b   Sun, Shu Han ^a   Zhou, Wei Ping ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; LncRNA; Methylation; Splicing; SRHC

Indexed keywords

LONG UNTRANSLATED RNA;

ADULT; AGED; CASE CONTROL STUDY; CELL PROLIFERATION; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC EPIGENESIS; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; PATHOLOGY; TUMOR CELL CULTURE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CELL PROLIFERATION; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RNA, LONG NONCODING; TUMOR CELLS, CULTURED;

EID: 84938534299     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1871-4     Document Type: Article

References (34)

1. Block TM, Mehta AS, Fimmel CJ, Jordan R (2003) Molecular viral oncology of hepatocellular carcinoma. Oncogene 22(33):5093–5107. doi:10.1038/sj.onc.1206557
2. Budhu A, Forgues M, Ye QH, Jia HL, He P, Zanetti KA, Wang XW (2006) Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell 10(2):99–111. doi:10.1016/j.ccr.2006.06.016
3. Chen CJ, Chen DS (2002) Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology. Hepatology 36(5):1046–1049. doi:10.1053/jhep.2002.37084
4. Du Y, Kong G, You X, Zhang S, Zhang T, Gao Y, Zhang X (2012) Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem 287(31):26302–26311. doi:10.1074/jbc.M112.342113
5. Eissmann M, Gutschner T, Hammerle M, Gunther S, Caudron-Herger M, Gross M, Diederichs S (2012) Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development. RNA Biol 9(8):1076–1087. doi:10.4161/rna.21089
6. El-Serag HB (2012) Surveillance for hepatocellular carcinoma: long way to achieve effectiveness. Dig Dis Sci 57(12):3050–3051. doi:10.1007/s10620-012-2413-z
7. Gonzalez FJ (2008) Regulation of hepatocyte nuclear factor 4 alpha-mediated transcription. Drug Metab Pharmacokinet 23(1):2–7
8. Hayhurst GP, Lee YH, Lambert G, Ward JM, Gonzalez FJ (2001) Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol 21(4):1393–1403. doi:10.1128/MCB.21.4.1393-1403.2001
9. Huang JF, Guo YJ, Zhao CX, Yuan SX, Wang Y, Tang GN, Sun SH (2013) Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin. Hepatology 57(5):1882–1892. doi:10.1002/hep.26195
10. Inoue Y, Peters LL, Yim SH, Inoue J, Gonzalez FJ (2006a) Role of hepatocyte nuclear factor 4alpha in control of blood coagulation factor gene expression. J Mol Med (Berl) 84(4):334–344. doi:10.1007/s00109-005-0013-5
11. Inoue Y, Yu AM, Yim SH, Ma X, Krausz KW, Inoue J, Gonzalez FJ (2006b) Regulation of bile acid biosynthesis by hepatocyte nuclear factor 4alpha. J Lipid Res 47(1):215–227. doi:10.1194/jlr.M500430-JLR200
12. Lagisetti C, Palacios G, Goronga T, Freeman B, Caufield W, Webb TR (2013) Optimization of antitumor modulators of pre-mRNA splicing. J Med Chem 56(24):10033–10044. doi:10.1021/jm401370h
13. Lan SH, Wu SY, Zuchini R, Lin XZ, Su IJ, Tsai TF, Liu HS (2014) Autophagy suppresses tumorigenesis of hepatitis B virus-associated hepatocellular carcinoma through degradation of microRNA-224. Hepatology 59(2):505–517. doi:10.1002/hep.26659
14. Lazarevich NL, Cheremnova OA, Varga EV, Ovchinnikov DA, Kudrjavtseva EI, Morozova OV, Duncan SA (2004) Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors. Hepatology 39(4):1038–1047. doi:10.1002/hep.20155
15. Liu Y, Zhang JB, Qin Y, Wang W, Wei L, Teng Y, Xie Y (2013) PROX1 promotes hepatocellular carcinoma metastasis by way of up-regulating hypoxia-inducible factor 1alpha expression and protein stability. Hepatology 58(2):692–705. doi:10.1002/hep.26398
16. Nagano T, Fraser P (2011) No-nonsense functions for long noncoding RNAs. Cell 145(2):178–181. doi:10.1016/j.cell.2011.03.014
17. Ning BF, Ding J, Yin C, Zhong W, Wu K, Zeng X, Xie WF (2010) Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. Cancer Res 70(19):7640–7651. doi:10.1158/0008-5472.CAN-10-0824
18. Orom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G, Shiekhattar R (2010) Long noncoding RNAs with enhancer-like function in human cells. Cell 143(1):46–58. doi:10.1016/j.cell.2010.09.001
19. Prensner JR, Chinnaiyan AM (2011) The emergence of lncRNAs in cancer biology. Cancer Discov 1(5):391–407. doi:10.1158/2159-8290.CD-11-0209
20. Prensner JR, Iyer MK, Sahu A, Asangani IA, Cao Q, Patel L, Chinnaiyan AM (2013) The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex. Nat Genet 45(11):1392–1398. doi:10.1038/ng.2771
21. Qureshi IA, Mattick JS, Mehler MF (2010) Long non-coding RNAs in nervous system function and disease. Brain Res 1338:20–35. doi:10.1016/j.brainres.2010.03.110
22. Sladek FM (1993) Orphan receptor HNF-4 and liver-specific gene expression. Receptor 3(3):223–232
23. Sladek FM, Zhong WM, Lai E, Darnell JE Jr (1990) Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev 4(12B):2353–2365
24. Tan YJ (2011) Hepatitis B virus infection and the risk of hepatocellular carcinoma. World J Gastroenterol 17(44):4853–4857. doi:10.3748/wjg.v17.i44.4853
25. Tripathi V, Shen Z, Chakraborty A, Giri S, Freier SM, Wu X, Prasanth KV (2013) Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet 9(3):e1003368. doi:10.1371/journal.pgen.1003368
26. van Malenstein H, Verslype C, Windmolders P, van Eijsden R, Nevens F, van Pelt J (2012) Characterization of a cell culture model for clinically aggressive hepatocellular carcinoma induced by chronic hypoxia. Cancer Lett 315(2):178–188. doi:10.1016/j.canlet.2011.09.039
27. Walesky C, Edwards G, Borude P, Gunewardena S, O’Neil M, Yoo B, Apte U (2013) Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents. Hepatology 57(6):2480–2490. doi:10.1002/hep.26251
28. Whittaker S, Marais R, Zhu AX (2010) The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 29(36):4989–5005. doi:10.1038/onc.2010.236
29. Wilusz JE, Sunwoo H, Spector DL (2009) Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 23(13):1494–1504. doi:10.1101/gad.1800909
30. Xu L, Hui L, Wang S, Gong J, Jin Y, Wang Y, Hu G (2001) Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma. Cancer Res 61(7):3176–3181
31. Xu Y, Hu B, Choi AJ, Gopalan B, Lee BH, Kalady MF, Ting AH (2012) Unique DNA methylome profiles in CpG island methylator phenotype colon cancers. Genome Res 22(2):283–291. doi:10.1101/gr.122788.111
32. Yang F, Huo XS, Yuan SX, Zhang L, Zhou WP, Wang F, Sun SH (2013) Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol Cell 49(6):1083–1096. doi:10.1016/j.molcel.2013.01.010
33. Zhang L, Yang F, Yuan JH, Yuan SX, Zhou WP, Huo XS, Sun SH (2013) Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis 34(3):577–586. doi:10.1093/carcin/bgs381
34. Zhu Z, Gao X, He Y, Zhao H, Yu Q, Jiang D, Gao Y (2012) An insertion/deletion polymorphism within RERT-lncRNA modulates hepatocellular carcinoma risk. Cancer Res 72(23):6163–6172. doi:10.1158/0008-5472.CAN-12-0010